CYPHERPUNK TECHNOLOGIES INC. Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent
CYPHERPUNK TECHNOLOGIES INC. (CYPH) had Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent of $40.00 thousand as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent · last filed 2023-05-15
- 2023-03-31: Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent $40.00K.
- 2020-12-31: Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent $204.00K.
- 2020-09-30: Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent $66.00K.
- 2019-12-31: Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent $159.00K.
| Period end | Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent |
|---|---|
| 2023-03-31 | $40.00K 10-Q · filed 2023-05-15 |
| 2020-12-31 | $204.00K 10-K · filed 2022-03-11 |
| 2020-09-30 | $66.00K 10-Q · filed 2020-11-12 |
| 2019-12-31 | $159.00K 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |